BioToChina.org partnering with YAFO Life Science and CHBD have successfully organized the largest online corporate access event between China and Western biopharma industry on May 15th and 22nd. We helped 35 overseas companies from 10 countries covering America, Asia, Europe, and China efficiently present their assets online in front of hundreds of big pharmaceutical companies in China.
– Presenting Companies: 35 companies from 10 countries
– Total audience: 1858 viewers for 35 presenting companies.
– Follow-up meeting: 500+ requests for asset presenting opportunities.
– Assets: 100+ assets looking for China or global partnering or funding. 【Follow us on Linkedin & EventBrite to DOWNLOAD Asset List】
For the Spring Event, we had 1858 viewers for the 35 presenting companies and 100+ assets looking for China or global partnering or funding. After the conference, we have gathered over 500+ follow-up requests for the presented partnering and investment opportunities. YAFO Life Science team will continue to follow up with potential investors, and arrange one-on-one meetings.
We cordially invite you to present or attend our ACCESS CHINA Summer event. Participation is FREE-OF-CHARGE.
SAVE THE DATE – July 31, 2020 SUMMER EVENT
The most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. Access China creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations.
YAFO Life Science
The investment banking division of YAFO Capital with a focus on global biopharma licensing, financing, and M&A, representing leading healthcare clients from the U.S., Europe, Israel, and Asia. YAFO Life Science is dedicated to bringing global pharmaceutical and medical device products to China.